A Biotechnology ETF Proving Immune to Hawkish Fed Policy Changes
May 04, 2016 at 12:43 PM EDT
Biotechnology exchange traded funds are still scuffling on a year-to-date basis, but some members of that group have recently been showing signs of life, including the BioShares Biotechnology Products Fund (NasdaqGM: BBP). BBP is up more than 2% over the past month. For years, there were only five...